This article is more than 5 years old. Information may no longer be current.

Arthrosurface receives 510(k) clearance for Patellofemoral WaveKahuna Arthroplasty System

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Arthrosurface Inc. announced it has received 510(k) clearance from the FDA to market its Patellofemoral WaveKahuna Arthroplasty System.

The Patellofemoral (PF) WaveKahuna Arthroplasty System is an extension of the products in the company’s HemiCAP Patellofemoral & PF Wave Systems product family, all of which are cleared and commercially marketed, according to a company press release.

The PF WaveKahuna system is designed to restore the articular surface geometry of the patella and femoral trochlea in order to help maintain the patient’s native knee anatomy. According to the release, the system also helps patellofemoral tracking and stability with its trochlear geometry and extended lateral aspect.

“As a market leader in patellofemoral arthroplasty, we are very excited to round out our line with the PF WaveKahuna System. The larger implants will allow a surgeon to choose from a wide range of size offerings to better serve the patient’s needs and allow them to maintain their quality of life,” Shane Shankle, Arthrosurface vice president of U.S. sales, said in the press release.

Reference:

https://www.arthrosurface.com/